Nbt Bank N A Merck & Co., Inc. Transaction History

Nbt Bank N A

$1.43 Billion
Q4 2024

A detailed history of Nbt Bank N A transactions in Merck & Co., Inc. stock. As of the latest transaction made, Nbt Bank N A holds 100,704 shares of MRK stock, worth $9.01 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares

100,704

Previous 101,464 0.75%

Holding current value

$9.01 Million

Previous $11.5 Million 13.05%

% of portfolio

0.7%

Previous 0.78%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	SELL	$96.31 - $114.76 $73,195 - $87,217	-760 Reduced 0.75%	100,704 $10 Million
Q3 2024 Nov 14, 2024	SELL	$111.15 - $128.97 $267,093 - $309,914	-2,403 Reduced 2.31%	101,464 $11.5 Million
Q2 2024 Jul 30, 2024	SELL	$123.8 - $132.96 $137,418 - $147,585	-1,110 Reduced 1.06%	103,867 $12.9 Million
Q1 2024 Apr 24, 2024	SELL	$113.24 - $131.95 $174,389 - $203,202	-1,540 Reduced 1.45%	104,977 $13.9 Million
Q4 2023 Feb 09, 2024	BUY	$100.18 - $109.02 $227,709 - $247,802	2,273 Added 2.18%	106,517 $11.6 Million
Q3 2023 Oct 26, 2023	BUY	$102.95 - $114.33 $4.94 Million - $5.49 Million	47,995 Added 85.33%	104,244 $10.7 Million
Q2 2023 Jul 24, 2023	SELL	$108.61 - $118.38 $144,668 - $157,682	-1,332 Reduced 2.31%	56,249 $6.49 Million
Q1 2023 May 02, 2023	SELL	$102.94 - $114.86 $245,614 - $274,055	-2,386 Reduced 3.98%	57,581 $6.13 Million
Q4 2022 Feb 10, 2023	SELL	$87.44 - $112.11 $204,347 - $262,001	-2,337 Reduced 3.75%	59,967 $6.65 Million
Q3 2022 Nov 08, 2022	BUY	$84.53 - $94.96 $16,314 - $18,327	193 Added 0.31%	62,304 $5.37 Million
Q2 2022 Jul 26, 2022	BUY	$83.49 - $94.64 $79,565 - $90,191	953 Added 1.56%	62,111 $5.66 Million
Q1 2022 Apr 29, 2022	SELL	$73.51 - $82.4 $96,445 - $108,108	-1,312 Reduced 2.1%	61,158 $5.02 Million
Q4 2021 Jan 27, 2022	BUY	$72.28 - $90.54 $939 - $1,177	13 Added 0.02%	62,470 $4.79 Million
Q3 2021 Oct 18, 2021	BUY	$71.68 - $78.83 $25,016 - $27,511	349 Added 0.56%	62,457 $4.69 Million
Q2 2021 Jul 28, 2021	SELL	$70.31 - $77.77 $23,624 - $26,130	-336 Reduced 0.54%	62,108 $4.83 Million
Q1 2021 Apr 08, 2021	SELL	$68.86 - $81.11 $73,749 - $86,868	-1,071 Reduced 1.69%	62,444 $4.81 Million
Q4 2020 Jan 15, 2021	SELL	$71.77 - $79.65 $7,535 - $8,363	-105 Reduced 0.17%	63,515 $5.2 Million
Q3 2020 Oct 29, 2020	SELL	$73.18 - $82.95 $20,929 - $23,723	-286 Reduced 0.45%	63,620 $5.28 Million
Q2 2020 Jul 22, 2020	SELL	$70.42 - $80.13 $18,942 - $21,554	-269 Reduced 0.42%	63,906 $4.94 Million
Q1 2020 Apr 23, 2020	SELL	$63.36 - $87.82 $81,417 - $112,848	-1,285 Reduced 1.96%	64,175 $4.94 Million
Q4 2019 Feb 05, 2020	SELL	$77.58 - $87.54 $88,441 - $99,795	-1,140 Reduced 1.71%	65,460 $5.95 Million
Q3 2019 Nov 12, 2019	BUY	$76.08 - $82.93 $43,669 - $47,601	574 Added 0.87%	66,600 $5.61 Million
Q2 2019 Aug 07, 2019	SELL	$69.84 - $81.59 $2,584 - $3,018	-37 Reduced 0.06%	66,026 $5.54 Million
Q1 2019 May 06, 2019	SELL	$69.58 - $79.36 $134,080 - $152,926	-1,927 Reduced 2.83%	66,063 $5.49 Million
Q4 2018 Feb 14, 2019	SELL	$65.24 - $75.71 $456 - $529	-7 Reduced 0.01%	67,990 $5.2 Million
Q3 2018 Nov 09, 2018	SELL	$57.69 - $67.84 $222,221 - $261,319	-3,852 Reduced 5.36%	67,997 $4.82 Million
Q2 2018 Jul 31, 2018	SELL	$50.83 - $59.72 $212,367 - $249,510	-4,178 Reduced 5.5%	71,849 $4.36 Million
Q1 2018 May 22, 2018	SELL	$50.96 - $59.23 $52,335 - $60,829	-1,027 Reduced 1.33%	76,027 $4.14 Million
Q4 2017 Feb 14, 2018	SELL	$51.62 - $61.64 $118,880 - $141,956	-2,303 Reduced 2.9%	77,054 $4.34 Million
Q3 2017 Nov 07, 2017	BUY	$58.67 - $63.13 $33,735 - $36,299	575 Added 0.73%	79,357 $5.08 Million
Q2 2017 Aug 08, 2017	BUY	N/A	78,782	78,782 $5.05 Million

Others Institutions Holding MRK

# of Institutions

3,952

Shares Held

1.94B

Call Options Held

16M

Put Options Held

15M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $227B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nbt Bank N A , based on Form 13F filings with the SEC.

News

Stay updated on Nbt Bank N A with notifications on news.

Account